SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management

• Status: Enrolling by invitation
• Trial end date: 2026-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This purpose of this study is to determine the efficacy of nonopioid versus opioid analgesic regimens following surgical fixation of Gartland Type III Supracondylar Humoral Fractures (SCHFs) to assist in the development of a standard outpatient pain management regimen in the treatment of these injuries.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Mercy Hospital Kansas City
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Hydrocodone; Ibuprofen

Criteria

Inclusion Criteria:

• Patients presenting to Children's Mercy Hospital

• Patients 48-119 months of age

• Closed and completely displaced Gartland type III SCHFs (ICD-10 codes: S42.411A, S42.412A and S42.413A)

Exclusion Criteria:

• Patients younger than 48 months of age or older than 120 months of age

• Nondisplaced SCHFs (ICD-10): S42.414-, S42.415- and S42.416-)

• Open and completely displaced Gartland type III SCHFs (ICD-10: S42.411B, S42.412B and S42.413B)

• Injury requiring open reduction and/or vascular injury requiring treatment

• Patients presenting with additional injuries

• Patients with known allergy to medications used in this study

• Patients receiving regular treatment with opioids or NSAIDs

• Patients with underlying medical issues affecting cognitive status

• Patients with hepatic, gastrointestinal, renal or hematologic disease/disorders

• Children that are wards of the state, prisoners or of CM employees

• Non-English speaking families

• Patients not admitted before and after surgery

• Fractures not surgically treated within 18 hours of injury

• Use of local anesthetic at surgical site